MuscleMecca Crew
MuscleMecca Crew
Staff
Author
- Joined
- May 11, 2012
- Messages
- 4,318
- Points
- 83
Mike Roberto dives deep into the reality of supplement research, intellectual property, and the often-murky waters of industry claims. He explains how patented ingredients can push companies toward funding human trials, while non-patented ones often rely on anecdote and smaller-scale studies. Mike emphasizes the value of pre-clinical animal research for understanding mechanisms but insists that credible human trials are the gold standard.
The discussion covers the controversial case of Turkesterone, with Mike recalling small, promising Uzbek studies and a later U.S. study by Dr. Jose Antonio that found no effect. This sparked friction with Greg Doucette, who believed Mike had pushed for the study. Mike’s takeaway: if influencers are making big money off these compounds, they should fund rigorous testing themselves.
He also revisits his own 2009 BCAA study, which unexpectedly showed massive gains—nine pounds of lean mass and four pounds of fat loss in 12 weeks for the BCAA group, compared to more modest results with whey protein or placebo. While the results were so good even he doubted them, the study was double-blind, published, and remains intriguing enough that he challenges modern brands to replicate it before making big claims.
Ultimately, Mike warns against baseless marketing and stresses the need for repeatable, well-funded studies. Whether it’s Turkesterone, Ecdysterone, or BCAAs, he believes the industry needs more transparency, replication, and science-backed claims—because without it, the hype cycle will just keep coming back every few years.
The discussion covers the controversial case of Turkesterone, with Mike recalling small, promising Uzbek studies and a later U.S. study by Dr. Jose Antonio that found no effect. This sparked friction with Greg Doucette, who believed Mike had pushed for the study. Mike’s takeaway: if influencers are making big money off these compounds, they should fund rigorous testing themselves.
He also revisits his own 2009 BCAA study, which unexpectedly showed massive gains—nine pounds of lean mass and four pounds of fat loss in 12 weeks for the BCAA group, compared to more modest results with whey protein or placebo. While the results were so good even he doubted them, the study was double-blind, published, and remains intriguing enough that he challenges modern brands to replicate it before making big claims.
Ultimately, Mike warns against baseless marketing and stresses the need for repeatable, well-funded studies. Whether it’s Turkesterone, Ecdysterone, or BCAAs, he believes the industry needs more transparency, replication, and science-backed claims—because without it, the hype cycle will just keep coming back every few years.
